2019
DOI: 10.1007/s00204-019-02555-x
|View full text |Cite
|
Sign up to set email alerts
|

Highlight report: hepatotoxicity of triazole fungicides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…In search of new potent inhibitors with selectivity to individual CDKs, we took advantage of the structure of PHA-793887 for the design of imidazole-4-N-acetamide-based CDK inhibitors [10]. Triazol-and pyrazol-containing compounds are known to evoke liver toxicity [11,12]. Furthermore, the pyrazole cycle was shown to mediate oxidative liver injury [13,14].…”
Section: Introductionmentioning
confidence: 99%
“…In search of new potent inhibitors with selectivity to individual CDKs, we took advantage of the structure of PHA-793887 for the design of imidazole-4-N-acetamide-based CDK inhibitors [10]. Triazol-and pyrazol-containing compounds are known to evoke liver toxicity [11,12]. Furthermore, the pyrazole cycle was shown to mediate oxidative liver injury [13,14].…”
Section: Introductionmentioning
confidence: 99%
“…The blocking of sterol 14α demethylase results in a deficiency of ergosterol, which is essential for cell membranes in yeast and fungi [6][7][8]. It has been shown that fungicides have toxic effects on mammal organisms [9][10][11] and numerous studies have revealed that EPX produced brain, cardiac, liver, kidney, intestinal, and endocrine-disrupting toxicity [12][13][14][15][16][17]. There have been few studies on metabolic toxicity and intestinal barrier function impairment in mice.…”
Section: Introductionmentioning
confidence: 99%